
Overview
Status
Active
Registry date
2021-04-16
Share capital
5,000.00 PLN
Activity description
Frexemed offers dietary supplements. It operates in the dietary supplements sector.
Registered address
Wiejska 47E, 05-552 Łazy, Poland
Website
Electronic delivery address
AE:PL-85964-31565-FDADR-23
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk.
From the notes
| Current income tax (CIT due) | $1,831 | |
| Profit allocation | Covers prior losses | |
| Loans and borrowings | $246,685 | |
| Revenue structure | Sprzedaż usług | |
| Related parties | 1 items |
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 342 days late).
- 202513/07/2026
- 202411/07/2025
- 202324/05/2024
- 202222/06/2023
- 202122/06/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles18,010 / 29,903
Top 60%
Results vs industry
Revenue
This companyUSD 481.06kMedianUSD 983.52kAverageUSD 9.58m
Net profit
This companyUSD -40.97kMedianUSD 15.85kAverageUSD 775.01k
Operating costs
This companyUSD 503.86kMedianUSD 948.35kAverageUSD 8.60m
Assets
This companyUSD 655.63kMedianUSD 418.31kAverageUSD 4.52m
Industry
Trademarks
Frexemed holds 3 active trademarks registered with the Polish Patent Office. The first mark was filed in 2025.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| SUPLARNIA(word) | Z.579682 | 35 | Protected | Jan 27, 2035 | |
| suplarnia. | Z.579683 | 35 | Protected | Jan 27, 2035 | |
| SUP. | Z.579684 | 35 | Protected | Jan 27, 2035 |
| Mark | Protected until | |
|---|---|---|
| SUPLARNIA(word) | Jan 27, 2035 | |
| suplarnia. | Jan 27, 2035 | |
| SUP. | Jan 27, 2035 |
Authorized Representatives
Katarzyna Dominika Adamska – Management Board Member
Piotr Wojciech Wąs – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Katarzyna Dominika Adamskaage 47 | 50 | $675.31 | 50% |
Piotr Wojciech Wąsage 51 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-04-08.
19 1600 1286 1736 8553 9000 0002
46 1600 1286 1736 8553 9000 0001
89 1600 1286 1736 8553 9000 0003
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medimessp. z o.o. | $1,317,775.92 | medimes.pl | ||
| Kleemed Pharmaceuticals Polandsp. z o.o. | $847,166.12 | kleemed.com.pl | ||
| Goodwill Pharma Polskasp. z o.o. | $664,724.30 | goodwillpharma.com | ||
| Goldfarmexsp. z o.o. | $625,453.25 | goldfarmex.pl | ||
| Medis Polandsp. z o.o. | $487,846.47 | medis.com | ||
| Best Medicsp. z o.o. | $332,392.46 | bestmedic.pl | ||
| GSH Polskasp. z o.o. | $313,619.12 | gshpolska.pl | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Domowa Apteczkasp. z o.o. | $188,954.12 | domowaapteczka.pl | ||
| Food SectorP.S.A. | $180,336.24 | foodsector.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-07-31 | Address change (Ul. Przasnyska 2/146, 01-756, Warszawa → Wiejska 47e, 05-552, Łazy) | |
| 2023-05-31 | Address change (Ul. Młynarska 35/10, 01-175, Warszawa → Ul. Przasnyska 2/146, 01-756, Warszawa) | |
| 2023-05-31 | Name change (For Me → Frexemed) | |
| 2021-04-16 | Entered in the register |
FAQ
The main business activity of Frexemed focuses on manufacture of other food products not elsewhere classified.
The company was registered in the Polish National Court Register (KRS) on April 16, 2021.
The headquarters is located at: ul. Przasnyska 2, 01-756 Warszawa.
The management board consists of: Katarzyna Dominika Adamska (Member of the Management Board) and Piotr Wojciech Wąs (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $920,712, representing an increase of 3.8% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $52,603.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $797,153 in 2024, representing 83% of all operating expenses.
Last updated: 2026-07-31